Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Radcliffe Department of Medicine (RDM) group awarded £2.55 million for diabetes research.

Inside of a laboratory © Diabetes UK

Today the Type 1 Diabetes Grand Challenge, a ground-breaking partnership between the Steve Morgan Foundation, Diabetes UK and  Juvenile Diabetes Research Foundation (JDRF) UK, has announced funding of a research project led from the University, in a bid to find a cure for type 1 diabetes.

Professor David Hodson and his team will receive £2.55 million to explore how insulin-boosting molecules, which sit on the surface of beta cells, could be harnessed to create better performing lab-grown beta cells. They will also explore if the specialised molecules could help to protect transplanted beta cells from the immune system, or trigger new beta cells to grow inside the pancreas.

 

Read the full story on the Radcliffe Department of Medicine website.

Similar stories

Sixty Seconds with Professor Alan Bernstein

Professor Alan Bernstein is Director of Global Health. The Oxford Global Health initiative brings together researchers from diverse disciplines and showcases the ongoing range of impactful global health research at Oxford. In this Sixty Seconds interview, we hear from Alan about his career to date, his vision for Oxford Global Health, and the lessons he has learnt throughout his career.